Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
Maxime Taquet

Maxime Taquet

Associate Professor of Psychiatry, University of Oxford

Appears in 1 story

Notable Quotes

"We're seeing this strong protective signal for dementia in dataset after dataset, across multiple countries. That's what makes this compelling."

"We acknowledge a direct comparison between the AS01-adjuvanted RSV vaccine and the RSVpreF vaccine would have been stronger evidence, but brand names were not consistently available in patient records."

Stories

The vaccine that might prevent dementia

New Capabilities

Lead researcher on multiple vaccine-dementia studies

A shingles vaccine is showing up in dataset after dataset as a dementia preventer. Oxford researchers published results in Nature Medicine in July 2024 showing Shingrix—the recombinant shingles vaccine—cuts dementia risk by 17-20% compared to unvaccinated people. Stanford followed with a Cell study in December 2024 showing it might even slow progression in people already diagnosed, cutting dementia death risk by 29.5 percentage points. Then in April 2025, Geldsetzer's team published in Nature showing causal evidence from a natural experiment in Wales. By July 2025, GSK was presenting data at the Alzheimer's Association International Conference showing risk reductions as high as 51% in Southern California populations.

Updated Feb 2